Accessible
发表于 2025-3-30 10:08:49
Severely Obese 42-Year-Old with Psoriasis,o weigh more, first-line biological drug choices include infliximab and ustekinumab because they are weight based. On the other hand, systemic treatments can often cause adverse effects and metabolic derangements in these patients.
档案
发表于 2025-3-30 16:19:00
33-Year-Old Female with Psoriasis Planning for Pregnancy,sis if she were to become pregnant. She and her spouse were planning on conceiving a child in 6 months. Her current treatment regimen included adalimumab and methotrexate. She denied experiencing side effects with her medications. She was otherwise healthy and does not have any other medical illnesses.
遵循的规范
发表于 2025-3-30 20:28:16
https://doi.org/10.1007/978-3-319-52779-6psoriasis; biologics; phototherapy; cyclosporine; methotrexate; acitretin; apremilast; hepatitis; herpes zos
装勇敢地做
发表于 2025-3-31 00:06:12
Springer International Publishing AG 2017
Decongestant
发表于 2025-3-31 02:38:27
http://reply.papertrans.cn/23/2279/227882/227882_55.png
英寸
发表于 2025-3-31 08:53:39
Why States Desire for Missile Systems?,eeking an alternative treatment after multiple years of topical corticosteroid use with suboptimal results and difficulty applying the ointment on his entire body. The patient has a family history of psoriasis. He did not complain of joint tenderness, swelling, or stiffness.
invade
发表于 2025-3-31 12:58:44
http://reply.papertrans.cn/23/2279/227882/227882_57.png
deceive
发表于 2025-3-31 17:11:31
Role Transition as Social Dramae patient was referred to dermatology after failed empiric treatment with topical antifungal creams prescribed by his primary care physician. He reports being otherwise healthy and denied a family history of psoriasis.
询问
发表于 2025-3-31 19:23:47
https://doi.org/10.1007/b138916o weigh more, first-line biological drug choices include infliximab and ustekinumab because they are weight based. On the other hand, systemic treatments can often cause adverse effects and metabolic derangements in these patients.
plasma-cells
发表于 2025-4-1 00:32:39
http://reply.papertrans.cn/23/2279/227882/227882_60.png